Conference Coverage: ASH 2023 – Focus on Lymphoma
Lymphoma-specific discussions on latest research updates, therapeutic advances, and their application in clinical decision-making
December 15, 2023
FACULTY CHAIR
Brad S. Kahl, MD
Washington University School of Medicine, St Louis, MO, USA
Faculty Members
Sonali M. Smith, MD
University of Chicago, IL, USA
Stefan K. Barta, MD
Penn Medicine, Philadelphia, PA, USA
Gilles Salles, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD
University of Southampton, United Kingdom
Georg Hess, MD
Johannes Gutenberg University, Mainz, Germany
Paolo Ghia, MD, PhD
Università Vita Salute San Raffaele, Milan, Italy
REPORT SNAPSHOT
- Advances in Indolent Lymphomas (FL and MZL)
- Advances in DLBCL/Aggressive B-Cell Lymphoma Excluding CAR T
- CAR T in DLBCL/Aggressive B-Cell Lymphomas
- Advances in MCL
- Advances in CLL
- Advances in T-Cell Lymphoma
